CORONA REMEDIES
Back to Income Statement
|
CORONA REMEDIES Last 5 Year Total Expenditure History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Total Expenditure | ₹956 Cr | ₹8,597 Cr | ₹756 Cr | ₹756 Cr |
What is the latest Total Expenditure of CORONA REMEDIES ?
| Year | Total Expenditure |
|---|---|
| Mar2026 | ₹956 Cr |
| Mar2025 | ₹8,597 Cr |
| Mar2024 | ₹756 Cr |
| Mar2023 | ₹756 Cr |
How is Total Expenditure of CORONA REMEDIES Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2026 | ₹956 Cr | -88.88 | |
| Mar2025 | ₹8,597 Cr | 1,037.12 | |
| Mar2024 | ₹756 Cr | 0.00 | |
| Mar2023 | ₹756 Cr | - | |
Compare Total Expenditure of peers of CORONA REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CORONA REMEDIES | ₹12,744.0 Cr | -3.9% | 2.3% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,530.0 Cr | -0.4% | 0.9% | 19.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹219,675.0 Cr | -1.2% | 21.1% | 29.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,970.0 Cr | -2.3% | 0.3% | 34.8% | Stock Analytics | |
| CIPLA | ₹117,947.0 Cr | 0.7% | 1.5% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,601.2 Cr | -0.3% | -7.1% | -3.9% | Stock Analytics | |
CORONA REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CORONA REMEDIES | -3.9% |
2.3% |
|
| SENSEX | -0.1% |
2.4% |
-3.3% |
You may also like the below Video Courses